19/12/2022
Congratulations! 🎉🎉🎉
On 8th November 2019, Orient Biotech collaborated with USM for a clinical trial of sacha inchi supplement among the 3Hs patients.
Now, the clinical trial result is officially released by Dr Lee Lai Kuan, Principal Investigator of USM! 👍
The clinical results are:
- Plant-based sacha Inchi oil reduces the systolic and diastolic blood pressures in 3Hs patients
- The total cholesterol and low-density lipoprotein (LDL) profiles in the supplement group reduces significantly
- Sacha inchi oil supplementation reduces the risk of developing atherosclerosis
- Sacha inchi oil supplementation reduces the concentrations of multiple oxidative
This meaningful Industry-Academia Linkage has been made into a success of our company milestone 🤩
Great applause for this amazing result 👏👏👏
U.S. National Library of Medicine
ClinicalTrials.gov
identifier: NCT04920825
![# 荣获亚太top杰出企业大奖Orient的创业之路迎来了另一个肯定，2021-2023 亚太TOP杰出企业大奖。谢谢大家对我们27年的支持和鼓励， 我们会继续努力为大家带来更好的功能保健食品。[Orient] ODM 保健食品生产商 拥...](https://img3.findhealthclinics.org/072/267/120909510722678.jpg)
